Company intelligence / Profile preview

Selio Medical

Dublin, Ireland

Ownership: Private
Employees: ~2
Development stage: Other

Overview

Selio Medical has demonstrated positive pre-clinical results showing that its device forms a temporary pleural seal prior to lung biopsy, preventing pneumothorax in animal models. Four pre-clinical studies are completed; first-in-human trials were anticipated post-2019, but no published clinical data yet.

Therapeutic areas: OncologyPulmonology
Modalities: DeviceHydrogel-based drug delivery therapy
Industry: Surgical Medical Devices

Partnerships

Enterprise IrelandEIT HealthAmber (SFI-funded research centre, Trinity College Dublin)

Beyond the preview

Go deeper on Selio Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Selio Medical.

Explore the full profile